Navigation Links
Talecris Biotherapeutics Announces Revised Record Date and Meeting Date for Special Meeting of Shareholders
Date:1/14/2011

RESEARCH TRIANGLE PARK, N.C., Jan. 14, 2011 /PRNewswire/ -- Talecris Biotherapeutics Holdings Corp. (Nasdaq: TLCR) announced today that it has established a new record date and meeting date for the special meeting of shareholders to vote on the previously announced merger agreement under which Grifols (GRF.MC) will acquire TLCR.

TLCR shareholders of record at the close of business on January 11, 2011 will be entitled to vote at the special meeting.  The TLCR board set the date for the special meeting of shareholders to be held at 3:30 p.m., local time, on February 14, 2011, at Research Triangle Park Marriott, located at 4700 Guardian Drive, Durham, North Carolina 27703.  This date takes the place of the previously announced date of January 21, 2011.

About Talecris Biotherapeutics: Inspiration. Dedication. Innovation.

Talecris Biotherapeutics is a global biotherapeutic and biotechnology company that discovers, develops and produces critical care treatments for people with life-threatening disorders in a variety of therapeutic areas including immunology, pulmonology, neurology and hemostasis. For more information, please visit: www.talecris.com.


'/>"/>
SOURCE Talecris Biotherapeutics Holdings Corp.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Talecris Biotherapeutics Announces Jury Verdict in Contract Dispute
2. Talecris Biotherapeutics GmbH Awards Winners of the 7th Annual European ALTA Research Fellowship at 2010 ERS Meeting
3. Talecris Biotherapeutics to Report Second Quarter 2010 Financial Results
4. Talecris Biotherapeutics Announces Premerger HSR Filing
5. Lafmin Morgan Joins Talecris Biotherapeutics as Vice President, U.S. Product Management
6. Talecris Names John Perkins as Executive Vice President, Global Commercial Operations
7. Talecris Biotherapeutics to Present at the 2010 Citi Investment Research Global Health Care Conference
8. Talecris Added to NASDAQ Biotechnology Index
9. Talecris Biotherapeutics to Present at the Bank of America Merrill Lynch Health Care Conference
10. Talecris Biotherapeutics to Report First Quarter 2010 Financial Results
11. Siemens/Talecris Win Best Partnership in the Outsourcing Excellence Awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... Express Diagnostics Int’l, Inc. (EDI) , ... pleased to announce a sponsorship agreement with Erebus Motorsport ... distributor of DrugCheck® onsite testing devices, manufactured by EDI. ... Austin 400 May 17-19 in Austin, Texas. , Royal ... each car of the Erebus Motorsport team displaying the ...
(Date:5/22/2013)... 2013 Envera announced today that Michael ... Mr. McErlean has an extensive background in cell production ... his career. , Mike Matheny, President and ... have Mike join our team”. “Mike’s background is perfectly ... fermentation and downstream processing equipment”, added Matheny. “Mike’s ...
(Date:5/22/2013)... 2013 The ability to sequence ... information they encode. There are now a suite ... of ribosome protected fragments) that dramatically expand our ... speakers include Dr. Jonathan Weissman, an Investigator with ... Hughes Medical Institute, who will present recent applications ...
(Date:5/21/2013)... 22, 2013 First patients dosed ... glycopyrronium bromide designed using Prosonix, particle engineering platform ... portfolio of inhaled Respiratory Medicines by Design , ... that will assess its effect on lung function and ... with moderate to severe chronic obstructive pulmonary disease (COPD). ...
Breaking Biology Technology:Australian Distributor of Express Diagnostics Signs Sponsorship Agreement with V8 Supercar Team 2Envera Appoints Michael McErlean Fermentation Manager 2Monitoring Protein Synthesis One Codon at a Time Through Ribosome Profiling, a Webinar Hosted by Xtalks 2Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 2Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 3Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 4
... Feb. 14, 2012 Avaxia Biologics, Inc., a ... act locally within the gastrointestinal tract, announced today ... A angel-led financing.  Cherrystone Angels of Providence, Rhode ... Angels, Boston Harbor Angels, Launchpad Venture Group, Mass ...
... 13, 2012  Ten years ago today, a task force ... together to develop a strategy for Indiana,s life sciences ... life sciences companies and research institutions into a 21st-century ... BioCrossroads, that strategy has driven the state into the ...
... 13, 2012 Amgen (NASDAQ: AMGN ) will present ... Eastern Standard Time  on Thursday, Feb. 16, 2012, at the ... executive vice president and chief financial officer at Amgen, will ... be accessed from the Events Calendar on Amgen,s website, ...
Cached Biology Technology:Avaxia Biologics, Inc. Closes $4.1 Million Series A Financing to Advance Oral Antibodies for Inflammatory Bowel Disease 2Avaxia Biologics, Inc. Closes $4.1 Million Series A Financing to Advance Oral Antibodies for Inflammatory Bowel Disease 3BioCrossroads Commemorates Decade of Collaboration, Success for Indiana Life Sciences Sector 2BioCrossroads Commemorates Decade of Collaboration, Success for Indiana Life Sciences Sector 3
(Date:5/21/2013)... device attached to a whale entangled in fishing gear, ... changed a whale,s diving and swimming behavior. The monitoring ... and migrate, depletes their energy as they drag gear ... slow death. , The scientists in this entanglement response ... two-year-old female North Atlantic right whale called Eg 3911. ...
(Date:5/21/2013)... Wash. A new analysis shows that the nation,s ... of enough algae to produce up to 25 billion ... States, one-twelfth of the country,s yearly needs. , The ... resources that would be needed to grow significant amounts ... results were published in the May 7 issue of ...
(Date:5/21/2013)... Researchers at USC have found that a class of ... mice. , The drugs, known as "TSPO ligands," ... "We looked at the effects of TSPO ligand in ... stage, and in aged mice when pathology was quite ... Davis School of Gerontology. "TSPO ligand reduced measures of ...
Breaking Biology News(10 mins):Study reveals how fishing gear can cause slow death of whales 2Study reveals how fishing gear can cause slow death of whales 3Going green: Nation equipped to grow serious amounts of pond scum for fuel 2Going green: Nation equipped to grow serious amounts of pond scum for fuel 3Going green: Nation equipped to grow serious amounts of pond scum for fuel 4Drugs found to both prevent and treat Alzheimer's disease in mice 2
... identified the risk of major birth defects associated with ... most comprehensive study of its kind in the world, ... compared the risk of major birth defects for each ... IVF (in vitro fertilization), ICSI (intracytoplasmic sperm injection) and ...
... tumors affect an estimated 15 million women in the United ... high prevalence of the tumors, which occur in 60 percent ... unknown. New Northwestern Medicine preclinical research has for the ... a single stem cell that develops a mutation, starts to ...
... 4, 2012 Young men who play volleyball, basketball or ... increase bone mass and might gain protection from developing osteoporosis ... May issue of the Journal of Bone and Mineral ... of its kind, discovered that young men who actively resisted ...
Cached Biology News:Higher risk of birth defects from assisted reproduction 2Higher risk of birth defects from assisted reproduction 3Higher risk of birth defects from assisted reproduction 4A single stem cell mutation triggers fibroid tumors 2Study: Men who do load-bearing exercise in early 20s may be shielded from osteoporosis 2Study: Men who do load-bearing exercise in early 20s may be shielded from osteoporosis 3
Request Info...
Guinea Pig Complement...
Collected from sexually matured, mixed breed, mixed sex guinea pigs....
Silica bead method is an economic method of DNA extraction from agarose...
Biology Products: